Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial (Q34265202)

1 August 2017

Efficacy of sodium butyrate adjunct therapy in shigellosis: a randomized, double-blind, placebo-controlled clinical trial (English)

1 reference

1 August 2017

0 references

1 reference

10

Birgitta Agerberth

0 references

Rubhana Raqib

object named as

Rubhana Raqib

1

0 references

author name string

Protim Sarker

2

1 reference

1 August 2017

Akhirunnesa Mily

3

1 reference

1 August 2017

Nur Haque Alam

4

1 reference

1 August 2017

Abu Saleh Mohammed Arifuzzaman

5

1 reference

1 August 2017

Rokeya Sultana Rekha

6

1 reference

1 August 2017

Jan Andersson

7

1 reference

1 August 2017

Gudmundur H Gudmundsson

8

1 reference

1 August 2017

Alejandro Cravioto

9

1 reference

1 August 2017

10 May 2012

1 reference

1 August 2017

BMC Infectious Diseases

1 reference

1 August 2017

12

1 reference

1 August 2017

111

1 reference

Creative Commons Attribution 2.0 Generic

1 August 2017

start time

10 May 2012

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1471-2334-12-111

0 references

cites work

Phenylbutyrate counteracts Shigella mediated downregulation of cathelicidin in rabbit lung and intestinal epithelia: a potential therapeutic strategy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Potential beneficial effects of butyrate in intestinal and extraintestinal diseases.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Decrease in shigellosis-related deaths without Shigella spp.-specific interventions, Asia

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Bifidobacterium animalis subsp. lactis fermented milk product reduces inflammation by altering a niche for colitogenic microbes

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Regulation of inflammatory responses by gut microbiota and chemoattractant receptor GPR43

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Green banana reduces clinical severity of childhood shigellosis: a double-blind, randomized, controlled clinical trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Virulent Shigella flexneri subverts the host innate immune response through manipulation of antimicrobial peptide gene expression

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Review article: the role of butyrate on colonic function.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Involvement of different nuclear hormone receptors in butyrate-mediated inhibition of inducible NF kappa B signalling

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Improved outcome in shigellosis associated with butyrate induction of an endogenous peptide antibiotic

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Effects of topical treatment of sodium butyrate and 5-aminosalicylic acid on expression of trefoil factor 3, interleukin 1beta, and nuclear factor kappaB in trinitrobenzene sulphonic acid induced colitis in rats

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Inhibition of interferon gamma signaling by the short chain fatty acid butyrate

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Persistence of mucosal mast cells and eosinophils in Shigella-infected children

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Butyrate reduces colonic paracellular permeability by enhancing PPARgamma activation

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Antimicrobial peptides of multicellular organisms

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Microbes and microbial toxins: paradigms for microbial-mucosal interactions III. Shigellosis: from symptoms to molecular pathogenesis.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Butyrate inhibits inflammatory responses through NFkappaB inhibition: implications for Crohn's disease

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

The luminal short-chain fatty acid butyrate modulates NF-kappaB activity in a human colonic epithelial cell line

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Counter-regulatory effect of sodium butyrate on tumour necrosis factor-alpha (TNF-alpha)-induced complement C3 and factor B biosynthesis in human intestinal epithelial cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Physiological and anti-inflammatory roles of dietary fiber and butyrate in intestinal functions

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Persistence of local cytokine production in shigellosis in acute and convalescent stages.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Quantitative analysis of synovial membrane inflammation: a comparison between automated and conventional microscopic measurements

6 July 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-111

Butyrate enema therapy stimulates mucosal repair in experimental colitis in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-111

HDAC inhibition prevents NF-kappa B activation by suppressing proteasome activity: down-regulation of proteasome subunit expression stabilizes I kappa B alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-111

Butyrate inhibits NF-kappaB activation in lamina propria macrophages of patients with ulcerative colitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-111

Combined oral sodium butyrate and mesalazine treatment compared to oral mesalazine alone in ulcerative colitis: randomized, double-blind, placebo-controlled pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1471-2334-12-111

Downregulation of bactericidal peptides in enteric infections: a novel immune escape mechanism with bacterial DNA as a potential regulator

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Short-chain fatty acids improve clinical, pathologic, and microbiologic features of experimental shigellosis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Immunopathological patterns in the rectal mucosa of patients with shigellosis: expression of HLA-DR antigens and T-lymphocyte subsets

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Cytokine secretion in acute shigellosis is correlated to disease activity and directed more to stool than to plasma

9 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3447723

Management of acute severe colitis

9 December 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22574737

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1471-2334-12-111

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference